Treatment as Prevention-Provider Knowledge and Counseling Lag Behind Global Campaigns

Sheri A Lippman^{1

2}, Rebecca West¹, Francesc Xavier Gómez-Olivé², Hannah H Leslie³, Rhian Twine², Ann Gottert⁴, Kathleen Kahn^{2

5}, Audrey Pettifor^{2

6}

Affiliations

¹ Division of Prevention Science, University of California, San Francisco, San Francisco, CA.
² MRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
³ T.H. Chan School of Public Health, Department of Global Health and Population, Harvard University, Somerville, MA.
⁴ Population Council, HIV and AIDS Program, Washington, DC.
⁵ Division of Epidemiology and Global Health, Department of Public Health and Clinical Medicine, Umeå Centre for Global Health Research, Umeå University, Umeå, Sweden.
⁶ Gillings School of Global Public Health, Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC.

Sheri A Lippman et al. J Acquir Immune Defic Syndr. 2020.

. 2020 Feb 1;83(2):e9-e12.

doi: 10.1097/QAI.0000000000002197.

Sheri A Lippman^{1

2}, Rebecca West¹, Francesc Xavier Gómez-Olivé², Hannah H Leslie³, Rhian Twine², Ann Gottert⁴, Kathleen Kahn^{2

5}, Audrey Pettifor^{2

6}

¹ Division of Prevention Science, University of California, San Francisco, San Francisco, CA.
² MRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
³ T.H. Chan School of Public Health, Department of Global Health and Population, Harvard University, Somerville, MA.
⁴ Population Council, HIV and AIDS Program, Washington, DC.
⁵ Division of Epidemiology and Global Health, Department of Public Health and Clinical Medicine, Umeå Centre for Global Health Research, Umeå University, Umeå, Sweden.
⁶ Gillings School of Global Public Health, Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC.

No abstract available

References

1. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505. - PMC - PubMed
1. Eaton JW, Johnson LF, Salomon JA, et al. HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS medicine. 2012;9(7):e1001245. - PMC - PubMed
1. UNAIDS. Global AIDS Update 2016. Geneva: Joint United Nations Programme on HIV/AIDS; 31 May 2016.
1. The Lancet H. U=U taking off in 2017. Lancet HIV. 2017;4(11):e475. - PubMed
1. Mooney AC, Gottert A, Khoza N, et al. Men’s Perceptions of Treatment as Prevention in South Africa: Implications for Engagement in HIV Care and Treatment. AIDS Educ Prev. 2017;29(3):274–287. - PMC - PubMed